Home › Entities › clinical_trial › CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients

CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients

clinical trial
MedicalStudy clinical_trial Q64661367
Press Enter · cited answer in seconds

CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients

Summary

CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients is a clinical trial[1].

Key Facts

  • CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients is in the country of Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients — country (P17): Canada[2].
  • CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients is in the country of Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients — country (P17): United States[3].
  • CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients's instance of is recorded as Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients — instance of (P31): clinical trial[4].
  • CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients's start time is recorded as +2010-06-30T00:00:00Z[5].
  • CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients's end time is recorded as +2015-09-30T00:00:00Z[6].
  • CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients's number of participants is recorded as {'unit': '1', 'amount': '+43'}[7].
  • CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients's title is recorded as A Phase 3 Trial of Calfactant for ALI in Pediatric Leukemia and HSCT Patients[8].
  • CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients's short name is recorded as CALIPSO[9].
  • CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients's different from is recorded as Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients — different from (P1889): CALIPSO[10].
  • CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q5151', 'amount': '+18'}[11].
  • CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients's ClinicalTrials.gov ID is recorded as NCT00999713[12].
  • CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+21'}[13].
  • CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients's research intervention is recorded as Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients — research intervention (P4844): calfactant[14].
  • CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients's clinical trial phase is recorded as Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients — clinical trial phase (P6099): phase II clinical trial[15].
  • CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients's clinical trial phase is recorded as Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients — clinical trial phase (P6099): phase III clinical trial[16].
  • CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients's research site is recorded as Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients — research site (P6153): Phoenix Children's Hospital[17].
  • CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients's research site is recorded as Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients — research site (P6153): Pennsylvania State University[18].
  • CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients's research site is recorded as Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients — research site (P6153): Children's Hospital of Philadelphia[19].
  • CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients's research site is recorded as Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients — research site (P6153): UPMC Children's Hospital of Pittsburgh[20].
  • CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients's research site is recorded as Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients — research site (P6153): St. Jude Children's Research Hospital[21].
  • CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients's study type is recorded as Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients — study type (P8363): interventional study[22].

References

Programmatic citations — every numbered marker resolves to a verifiable graph row below.

Direct Wikidata claims

  1. [2] ↑ . wikidata.org.
  2. [3] ↑ . wikidata.org.
  3. [4] ↑ . wikidata.org.
  4. [5] ↑ . wikidata.org.
  5. [6] ↑ . wikidata.org.
  6. [7] ↑ . wikidata.org.
  7. [8] ↑ . wikidata.org.
  8. [9] ↑ . wikidata.org.
  9. [10] ↑ . wikidata.org.
  10. [11] ↑ . wikidata.org.
  11. [12] ↑ . wikidata.org.
  12. [13] ↑ . wikidata.org.
  13. [14] ↑ . wikidata.org.
  14. [15] ↑ . wikidata.org.
  15. [16] ↑ . wikidata.org.
  16. [17] ↑ . wikidata.org.
  17. [18] ↑ . wikidata.org.
  18. [19] ↑ . wikidata.org.
  19. [20] ↑ . wikidata.org.
  20. [21] ↑ . wikidata.org.
  21. [22] ↑ . wikidata.org.

Class ancestry

  1. [1] ↑ . Wikidata. wikidata.org.

📑 Cite this page

Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.

APA 4ort.xyz Knowledge Graph. (2026). CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients. Retrieved May 3, 2026, from https://4ort.xyz/entity/calipso-calfactant-for-acute-lung-injury-in-pediatric-stem-cell-transplant-and-oncology-patients
MLA “CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients.” 4ort.xyz Knowledge Graph, 4ort.xyz, 3 May. 2026, https://4ort.xyz/entity/calipso-calfactant-for-acute-lung-injury-in-pediatric-stem-cell-transplant-and-oncology-patients.
BibTeX @misc{4ortxyz_calipso-calfactant-for-acute-lung-injury-in-pediatric-stem-cell-transplant-and-oncology-patients_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients}}, year = {2026}, url = {https://4ort.xyz/entity/calipso-calfactant-for-acute-lung-injury-in-pediatric-stem-cell-transplant-and-oncology-patients}, note = {Accessed: 2026-05-03}}
LLM prompt According to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients — https://4ort.xyz/entity/calipso-calfactant-for-acute-lung-injury-in-pediatric-stem-cell-transplant-and-oncology-patients (retrieved 2026-05-03)

Canonical URL: https://4ort.xyz/entity/calipso-calfactant-for-acute-lung-injury-in-pediatric-stem-cell-transplant-and-oncology-patients · Last refreshed: